Force measurements in ex vivo and engineered heart tissues are well established. Analysis of calcium transients (CaT) is complementary to force, and the combined analysis is meaningful to the study of cardiomyocyte biology and disease. This article describes a model of human induced pluripotent stem cell cardiomyocyte-derived engineered heart tissues (hiPSC-CM EHTs) transduced with the calcium sensor GCaMP6f followed by sequential analysis of force and CaT. Average peak analysis demonstrated the temporal sequence of the CaT preceding the contraction twitch. The pharmacological relevance of the test system was demonstrated with inotropic indicator compounds. Force-frequency relationship was analyzed in the presence of ivabradine (300 nM), which reduced spontaneous frequency and unmasked a positive correlation of force and CaT at physiological human heart beating frequency with stimulation frequency between 0.75 and 2.5 Hz (force +96%; CaT +102%). This work demonstrates the usefulness of combined force/CaT analysis and demonstrates a positive force-frequency relationship in hiPSC-CM EHTs.
INTRODUCTION
Analysis of the contractile force of heart muscle trabeculae from laboratory animals or human hearts has been established for decades and has substantially contributed to the understanding of mechanisms and genes involved in force regulation. During the last decade, different technologies were established to generate contractile force in human induced pluripotent stem cell cardiomyocyte-derived engineered heart tissue (hiPSC-CM EHT) (Bielawski et al., 2016; Cashman et al., 2016; Hinson et al., 2016; Jackman et al., 2016; Kensah et al., 2013; Leonard et al., 2018; Mannhardt et al., 2016; Mills et al., 2017; Nunes et al., 2013; Ronaldson-Bouchard et al., 2018; Ruan et al., 2016; Tiburcy et al., 2017; Tulloch et al., 2011; Zhao et al., 2019) . Analysis of contractile force has been instrumental in the development of EHT models because it allows the force response to be compared with human heart tissue. The challenge of interpreting force data is related to their complex nature, i.e., alteration of numerous targets related to myofilaments, calcium-handling proteins, and other targets that affect force development. The combination of force analysis with readouts of cytoplasmic increase in calcium concentration (calcium transient, CaT) during systole and decrease during diastole is therefore a meaningful extension of contractility assays. Such assays for heart muscle trabeculae are established with aequorin Perreault et al., 1992) or calcium-sensitive dyes (Brixius et al., 2003 (Brixius et al., , 2002 Haizlip et al., 2015) . In anal-ogy, we and others (Nunes et al., 2013; Rao et al., 2018; Ronaldson-Bouchard et al., 2018; Ruan et al., 2016; Stoehr et al., 2014; Zhao et al., 2019) have established CaT measurements in different EHT models with calcium-sensitive dyes or genetically encoded calcium sensors (GECIs) for the characterization of EHTs.
The adaptation of force to changes in beating frequency (force-frequency relationship [FFR] or Bowditch effect) is well described for human myocardium (Mulieri et al., 1992; Pieske et al., 1999; Schmidt et al., 1995) . Mechanistically, the integrated dynamic balance of the intracellular calcium concentration is key to this phenomenon (Bers et al., 2014; Klabunde, 2012; Krishna et al., 2013) . With increasing stimulation frequency, calcium influx via the L-type calcium channels (LTCCs) and calcium uptake into the sarcoplasmic reticulum exceed calcium efflux via the sodium-calcium exchanger. In consequence, the amplitude of the CaT increases in a frequency-dependent manner. Important characteristics of this mechanism across several mammalian species are a positive correlation between both force and CaT amplitude with frequency at beating rates close to the physiological heart rate of the respective species. At higher frequencies, a dissociation between further increasing CaT amplitudes and a secondaryphase negative FFR was described (Endoh, 2004; Mulieri et al., 1992; Pieske et al., 1999) . In hiPSC-EHT models, the absence of a positive FFR was interpreted as an indicator of immaturity, and a positive correlation could be demonstrated only in the presence of electrical conditioning (Ronaldson-Bouchard et al., 2018; Zhao et al., 2019) or defined serum-free medium conditions (Tiburcy et al., 2017) .
In this article, we demonstrate an extension of video-optical analysis of contractile force in hiPSC-CM EHTs by sequential measurement of GCaMP6f-mediated fluorescence intensity, a surrogate for CaT, as a robust model to study cardiac physiology and pharmacology. Specifically, we demonstrate canonical effects of indicator compounds on CaT and force. Furthermore, we assess the correlation of CaT and force amplitude at physiological human heart rates by reducing spontaneous baseline frequency with the I f current inhibitor ivabradine. Under this condition, we unmasked a positive force-and CaT-frequency relationship between 0.75 and 2.5 Hz in the absence of electrical conditioning or defined serum-free medium. In aggregate, the data present an innovative model to analyze CaT and force in EHTs to study physiological mechanisms and pharmacological effects.
RESULTS

Specificity of Fluorescence Signal
Human iPSC-CMs were efficiently transduced with lentivirus encoding either GCaMP5G or GCaMP6f in a twodimensional (2D) monolayer, demonstrated by a bright GFP fluorescence signal during contraction (Figures 1A and 1B, and Videos S1, S2, S3, and S4). CaT and force were recorded from hiPSC-CM EHTs transduced with GCaMP5G or GCaMP6f. In GCaMP5G EHTs, kinetics of time-to-peak CaT (TTP À80%,CaT ; 0.181 ± 0.004 s) was 28% longer than time-to-peak force (TTP À80%,force ; 0.141 ± 0.001 s), and decay time of the CaT (DT 80% ; 0.329 ± 0.003 s) was 99% longer than relaxation time for force (RT 80%,force ; 0.165 ± 0.002 s; Figure 1C , left, Figure S1A ). This resulted in a clockwise orientation of the force-calcium loop ( Figure 1C, right) , and a faster contraction phase indicated by lower density of the data points marks the beginning of the loop. In GCaMP6f EHTs, TTP À80%,CaT was 20% shorter than TTP À80%,force (0.116 ± 0.004 s versus 0.145 ± 0.005 s), and DT 80%,CaT was 16% longer than RT 80%,force (0.173 ± 0.007 s versus 0.149 ± 0.003 s). This characteristic resulted in superimposition of the terminal phases of CaT and contraction ( Figure 1D , left, Figure S1B ) and a counterclockwise orientation of the force-calcium loop ( Figure 1D , right). We therefore focused on GCaMP6f for further characterization. Average force peaks of GCaMP5G-and GCaMP6f-transduced EHTs showed an overlap, while CaT average peaks demonstrated slower on-and-off kinetics for GCaMP5G ( Figure S1C ). Original CaT recordings showed strong signals and weak background noise. Signal-to-noise ratio was calculated as 64.2 ± 8.6, SEM (N: number of EHTs = 12 EHT recordings).
Histologically, GCaMP6f (transduced at the time of casting) did not interfere with myofilament organization or cellular alignment along the long axis of the EHT, as indicated by cardiac alpha-actin staining ( Figure S2B ). Staining for GFP revealed transduction of 20%-40% of hiPSC-CMs within the EHT (Figures S2C and S2D) .
To demonstrate the dependency of CaT amplitude on GCaMP6f expression, EHTs were transduced with GCaMP6f-AAV6-particles at two different multiplicities of infection (MOI, 7 3 10 4 and 7 3 10 5 ). Analysis of CaT and force ( Figure 1E ) revealed higher CaT amplitude for 7 3 10 5 MOI transduction (10, 885 versus 5, 192 AU, Figure S1D) , while force was not different (0.088 versus 0.086 mN, Figure S1 ). GCaMP6f EHTs were also analyzed at extracellular calcium concentrations of 0.6 and 1.8 mM. At 1.8 mM calcium, CaT amplitude was 185% higher (15,128 versus 5,318 AU) and force amplitude was 154% higher (0.165 versus 0.065 mN, Figures 1F and S1E) compared with 0.6 mM calcium.
Motion artifacts are a possible limitation of CaT recordings in auxotonic or isotonic contracting muscle tissues/cells (Kaestner et al., 2014) . To minimize the contribution of motion artifacts, GCaMP6f fluorescence was recorded at a rectangular window of 0.1 3 0.4 mm in the center of the EHT where motion during contraction is the least ( Figure S2E ). To understand the contribution of motion artifacts on CaT signals, autofluorescence was recorded in non-transduced EHTs (Figure 2A ) and GFP-transduced EHTs ( Figure 2B ). Peak amplitude of the autofluorescence or GFP fluorescence signals was more than 10-fold smaller than GCaMP5G or GCaMP6f signal intensities (which were in the range of 5,000-25,000 AU), and it was superimposed with the contraction twitch (Figures 2A and 2B, left) . This resulted in a symmetrical loop with similar data point density for the contraction and relaxation phases of force-fluorescence loops (Figure 2A , right) or linear force-light dependency (Figure 2B, right) . This supports the finding that the temporal sequence of CaT and force and the force-calcium loop shape ( Figures 1C and 1D ) represent specific signals. To determine whether the absence of contractile motion would affect CaT amplitude, GCaMP6f-EHTs were generated on hollow polydimethylsiloxane (PDMS) posts according to a previously established protocol that would enable stiffening of the flexible posts and therefore abrogate EHT movement (Hirt et al., 2012) . Recording of CaT and force for timematched controls (TMCs) revealed no change during the time course of the experiment ( Figure 2C , left). For the experimental group, introduction of metal braces reduced shortening/post deflection to nominally zero with minor reduction of CaT, which was reversed after removal of the metal braces ( Figure 2C, right) . In a second experiment to analyze CaT in the absence of contraction, GCaMP6f-EHTs were analyzed in the presence of 2,3-butanedione monoxime (BDM; 10 mM; experiments with blebbistatin were not successful because of strong autofluorescence; Képiró et al., 2014) . TMCs for this experiment showed again no significant changes in CaT, but force decreased by 21% ( Figure 2D , left). BDM reduced force by À85% and CaT by À44%. The reason for the BDM-induced reduction of CaT is not clear, but the low potency of BDM and thus the high working concentration likely result in multiple offtarget effects (Biermann et al., 1998) . Reproducibility of force and CaT recordings was analyzed by three repetitive measurements with 3 h intervals. While force values did not differ (0.238 ± 0.008, 0.230 ± 0.007, 0.230 ± 0.007, mN ± SEM, N = 16), CaT amplitudes showed 10% decline (8,003 ± 344, 7,241 ± 327, 7,293 ± 320, AU ± SEM, N = 15), likely a consequence of photo bleaching as recently reported for GCaMP6f (Li et al., 2019) (Figures S2F and S2G ). This finding implicates that the effect sizes for the repetitive CaT recording experiments might be slightly underestimated. (C) Average normalized CaT and force peaks of hiPSC-CM EHTs after lentiviral transduction with GCaMP5G (left). Depiction of the same data as a force-calcium loop, n = 5; 1; 1 (right). (D) Average normalized CaT and force peaks of hiPSC-CM EHTs after lentiviral transduction with GCaMP6f (left). Depiction of the same data as a force-calcium loop, n = 25; 3; 4 (right). (E) Average normalized force (left) and CaT (right) peaks of hiPSC-CM EHTs virally transduced with GCamP6f (AAV6, MOI 7 3 10 4 and 7 3 10 5 , n = 3; 1; 1). (F) Average normalized force (left) and CaT (right) peaks of hiPSC-CM EHTs virally transduced with AAV6-and LV-GCaMP6f at 0.6 and 1.8 mM Ca 2+ (n = 21; 3; 3). Replicates are indicated as number of independent samples; number of hiPSC cell lines; number of repeated measurements (N; nl; nm); N was used for statistics. Data are depicted as means ± SEM except for the force-calcium loops. Measurements were done in modified Tyrode's solution at 1.8 mM Ca 2+ under electrical stimulation of 1.5 Hz (C and D), 2.0 Hz (E), and 1.5 Hz for N = 17 and 2.0 Hz for N = 4 (F). See also Figure S1 .
Compound-Specific Effects
(10 nM) led to an increase in force (+51%) and reduction in TTP À80%,force and RT 80%,force (À17%) as expected. This was accompanied by an increase in CaT amplitude (+64%) and reduction in TTP À80%,CaT and RT 80%,CaT (À17%; 14%). Force-calcium loops demonstrated higher force and CaT maximum. The LTCC inhibitor nifedipine (10, 30, and 100 nM) led to a concentration-dependent decrease in force (À67%) and CaT (À77%). Also TTP À80%,force /TTP À80%,CaT and RT 80%,force /DT 80%,CaT were significantly reduced (À29%/À17% and À22%/À21%, respectively; 100 nM). Some EHTs stopped beating at 100 nM ( Figure S3B ). Forcecalcium loops demonstrated smaller force and CaT amplitude values. The LTCC agonist Bay K-8644 (300 nM) led to an increase in force (+71%) and RT 80%,force (+86%). This was accompanied by an increase in DT 80%,CaT (+74%). CaT amplitude increased at 30 and 100 nM (+53%, +62%) but not at 300 nM. Force-calcium loops demonstrated higher amplitudes for force and CaT at 30 nM and more force for a given calcium at 300 nM. The sodium/potassium ATPase inhibitor digoxin increased force and CaT at 300 nM (+87%, +142%), accompanied by a reduction in RT 80%,force and DT 80%,CaT (À19%, À27%). At 1 mM, digoxin led to a reduction in force by À50% and no change in CaT (À7%), compatible with its known toxicity at higher concentrations. Force-calcium loops demonstrated a harmonic increase in force and CaT at 300 nM and a drastic reduction in force at 1 mM. The myofilament calcium sensitizer EMD-57033 led to an increase in force (+130%) and TTP À80%,force (+15%) at 10 mM. CaT amplitude decreased (À50%) and TTP À80%,CaT increased (+21%). Force-calcium loops demonstrated a strong increase in force per calcium for contraction and relaxation and a higher force amplitude.
Force-Frequency Relationship
In recent studies, we were not able to demonstrate a positive FFR in hiPSC-CM EHTs (Mannhardt et al., 2016) , whereas others demonstrated FFR in the presence of electrical conditioning (Ronaldson-Bouchard et al., 2018; Zhao et al., 2019) or defined serum-free medium conditions (Tiburcy et al., 2017) . We hypothesized that a positive FFR in EHTs may be masked by a high spontaneous beating rate. Spontaneous beating of hiPSC-CMs is dependent on the I f current (Mannhardt et al., 2016) ; hence, we evaluated FFR in hiPSC-CM EHTs in the presence of ivabradine (300 nM), which reduces spontaneous beating frequencies to 25% (Mannhardt et al., 2016) . In the presence of ivabradine, hiPSC-CM EHTs could be paced at the physiological human heart rate, between 0.75 and 2.5 Hz (Figure 4) . Between 0.75 and 2.0 Hz, the increase in stimulation frequency was accompanied by an increase in force (+96%) and CaT (97%). At higher frequencies, up to 2.5 Hz, force values decreased (2.5 Hz: +82%). In contrast, CaT further increased (2.5 Hz: 102%) ( Figures 4A and 4B ). In parallel, TTP À80%,force , TTP 80%,CaT , RT 80%,force , and DT 80%,CaT declined by 10%-30% between 0.75 and 2.5 Hz. The same data are also demonstrated as average peaks and force-calcium loops (Figures 4C and 4D) . The correlation between force and CaT data at different frequencies demonstrates the dissociation between increasing CaT and force values above 2.0 Hz ( Figure 4E ). To understand the contribution of cytoplasmic expression of GCaMP6f, the experiment was repeated with non-transduced EHTs (Figure S5 ). This showed a maximal increase in force by +45% at 2.0 Hz. The difference in effect size is compatible with improvement of diastolic function by calcium buffering as shown for parvalbumin (Wang et al., 2013) .
Omecamtiv Mecarbil
Omecamtiv mecarbil (OM) binds the catalytic domain of myosin and thereby acts as a myosin activator. OM was demonstrated to increase force and TTP while CaT remained unchanged in rat cardiomyocytes (Malik et al., 2011) . Two previous studies demonstrated that the inotropic effect of OM showed reverse frequency dependency in canine myocytes (Butler et al., 2015; Horváth et al., 2017) . In analogy to the demonstration of a positive FFR (Figure 4) , the effect of OM (1 mM) was analyzed in the presence of ivabradine (300 nM) at frequencies between 0.75 and 2.5 Hz ( Figure 5 ). Human iPSC-CM EHTs followed the pacing signals at all frequencies ( Figures 5A and 5B) . The positive inotropic effect of OM was +99% at 0.75 Hz, decreased to +54% at 1.25 Hz, and was not significant at higher frequencies. OM prolonged TTP À80%,force and RT 80%,force , with maximal effects at 1.25 (79%) and 0.75 Hz (35%), respectively, with progressively smaller effects at higher stimulation rates ( Figures 5A and 5C ). CaT amplitude remained unchanged, while TTP À80%,CaT and DT 80%,CaT were maximally increased by $30% and 24% at 1.25 and 1.0 Hz, respectively, with smaller or no effects at higher stimulation rates ( Figures 5B and 5C ).
DISCUSSION
This study describes an advanced test system to analyze CaT and force in hiPSC-CM EHTs. The main findings are (1) demonstration of a temporal sequence of CaT amplitude preceding force amplitude; (2) insignificant contribution of motion artifact, demonstrated by lack of CaT change in the presence of contraction-abrogating afterload enhancement; (3) specific effects of indicator compounds on force and CaT, precisely replicating known mechanisms of action; (4) positive force-frequency and CaT-frequency relationships in the range of the physiological human heart beat; and (5) verification of a reverse correlation between frequency and inotropic effect of OM.
In a previous study, we demonstrated CaT analysis in hiPSC EHTs based on FURA-2 loading . However, variability in loading and sensitivity to washout during concentration-response curve analysis introduced artifacts that substantially compromised the use of this approach. The use of GECIs transduced with viral vehicles as applied in this study led to lower variability in fluorescence signals and lower sensitivity to washout. The family of GCaMP sensors is well established among GECIs (Kaestner et al., 2014) . Both vectors, AAV6 and lentiviral, are sufficient to transfect hiPSC-CMs in 2D and in 3D culture. For 3D, transfection of hiPSC-CM EHTs only a few days before analysis did not lead to CaT with sufficient signal-to-noise ratio; therefore, viral transduction was performed during casting. This led to long-term, stable GCaMP6f expression for weeks. This approach entails expression of sensors during the process of EHT development with potential off-target effects and lower force developments via calcium buffering. Nevertheless, this did not seem to be relevant, since development of force in GCaMP EHTs was not different from that in GCaMP-free EHTs. Also, non-linearity of signal intensity and non-ratiometric measurement are potential disadvantages of this approach (Rose et al., 2014) . Slow kinetics of genetically encoded versus dye-based indicators are described, and GCaMP6f was developed to overcome this limitation of earlier GCaMP generations (Chen et al., 2013) . Despite this improvement, time-to-CaT amplitude is reached slower than with dyes. In consequence, force-calcium loops Figure S5 .
from dye-based recordings show an initial phase of calcium rise and a second phase of force increase after calcium amplitude is reached , while these phases are merged in loops from GCaMP6f recordings.
Motion artifacts in CaT analysis of contracting muscles result from increase in fluorescence signal detection due to tissue compaction during contraction, but not higher cytoplasmic calcium concentration (Cleemann and Morad, 1991) . Hence, the kinetics of motion artifacts closely follow the kinetics of contraction. The difference in CaT and force kinetics, the dominant change in force in the presence of afterload enhancement and the myofilament calcium sensitizer EMD-57033, suggests that integrating the CaT signal from a defined area in the center of the EHT does not lead to relevant motion artifacts.
Characterization of indicator compounds revealed distinct, compound-specific effects on force and CaT. Notably, CaT amplitudes (isoprenaline, digoxin) and kinetics (isoprenaline, digoxin, Bay K-8644) were altered for compounds with inotropic effects. The lack of Bay K-8644-mediated increase in CaT amplitude at 300 nM is in concordance with past studies on this compound in hamster cardiomyocyte preparations and hiPSC-CMs (Cerignoli et al., 2012; Sen et al., 1990) . Likewise, the positive inotropic effect of the myofilament calcium sensitizer EMD-57033 was not associated with any changes in CaT, similar to past reports in rat papillary muscles (Ishitani et al., 2001) . Digoxin-mediated inhibition of sodium/potassium ATPase increased calcium load and led to a biphasic response. The increase in CaT and force amplitude at 300 nM was followed by a toxic effect at 1.0 mM in analogy with past reports on human ventricular myocardium (Näbauer and Erdmann, 1987) and chick embryonic myocardial myocytes (Toseland et al., 1996) .
The lack of a positive FFR in hiPSC-CM EHTs in past reports (Mannhardt et al., 2016) was interpreted as an indicator of cardiomyocyte immaturity. Notably, a positive FFR in the human non-failing heart in past reports was demonstrated between 0.2 and 2.9 Hz (Mulieri et al., 1992) , 0.5-2.5 Hz (Pieske et al., 1999) , and 0.1-2.5 Hz (Schmidt et al., 1995) . This is in line with the recognition that a positive FFR prevails in the range of the physiological heart rate for the respective species (Endoh, 2004) . In agreement with this, rabbit and rat trabeculae showed a positive FFR at 1 to 4 Hz and 4 to 8 Hz, respectively (Monasky and Janssen, 2009 ). Ivabradine has been used at a concentration (300 nM) that is not known to inhibit other ion currents. The half-maximal inhibitory concentration (IC 50 ) value of ivabradine needed to inhibit I f current in CHO cells was 0.54 mM (Thollon et al., 2007) . Compatible with this finding, it reduced spontaneous beating in hiPSC EHTs by 50% at 300 nM (Mannhardt et al., 2016) . At higher concentrations (e.g., 10 mM) ivabradine is not selective anymore and reduces I K and I Ca,L (Bois et al., 1996) . Reduction of baseline frequency with ivabradine in hiPSC-CM EHTs unmasked a positive FFR in a beating range close to the physiological human heartbeat, indicating that the complex calcium-handling machinery required for this physiological response is established in this model. Furthermore, a positive correlation between CaT and frequency and a dissociation of the force-frequency and CaT-frequency relationship at high pacing frequencies was demonstrated, which is in line with past reports on FFRs in different mammalian species Monasky and Janssen, 2009 ). The smaller FFR effect size versus adult myocardium (Monasky and Janssen, 2009 ) is compatible with an intermediate state of maturation. This is also in line with lower baseline force values for EHT versus adult myocardium. Nevertheless, relative changes to physiological stimuli and pharmacological interventions replicated findings in adult heart tissue (Mannhardt et al., 2016) . In addition, the dissociation of increasing CaT amplitude values from plateauing force amplitude values at the upper end of the physiological beating range is another characteristic of FFRs in mammalian species (Endoh, 2004; and could be replicated in this model. These data strengthen the finding that many physiological aspects of human heart tissue are replicated in the hiPSC-CM EHT model (Mannhardt et al., 2016) , but also point to the fact that sophisticated experimental conditions are required in some cases to demonstrate them.
The principle of lowering baseline frequency in hiPSC-CM EHTs with ivabradine to demonstrate FFR was taken forward to analyze the effect of OM. The data confirm the reverse frequency dependency of the inotropic effect previously reported in two canine models (Butler et al., 2015; Horváth et al., 2017) . Furthermore, the lack of increase in CaT amplitude is in agreement with myosin activation as a primary mode of action. The nature of the increase in TTP À80%,CaT and DT 80%,CaT is not known; similar trends were, however, recently reported in a canine myocyte model (Horváth et al., 2017) . Taken together, several physiological and pharmacological positive inotropic mechanisms were presented in this study, which modify either calcium handling (Bay K-8644, digoxin, FFR) or myofilaments (EMD-57033, OM) and are therefore associated with a variety of CaT amplitude and kinetics alterations, demonstrating the added value of a combined analysis.
Limitations of this study are (1) the sequential and not parallel recording of CaT and force, which increases experimental complexity and allows for measurements only at steady state and not of short and transient effects;
(2) the slower on-kinetics of GCaMP6f (versus calcium-sensitive dyes), reducing the significance of TTP À80%,CaT ; and (3) the experimental approach to transduce EHTs during casting, which reduces experimental flexibility.
In summary, this study describes a test system to monitor CaT and force in hiPSC-CM EHTs to study the physiology and pharmacology of cardiomyocytes with high accuracy.
EXPERIMENTAL PROCEDURES
Expansion and Differentiation of Human Induced Pluripotent Stem Cells
Cardiac differentiation of hiPSCs was performed as recently described (Breckwoldt et al., 2017) . In brief, hiPSCs were expanded on Geltrex-coated cell culture vessels with FTDA medium, and splitting was performed with EDTA. Formation of embryoid bodies was performed in spinner flasks, and differentiation was conducted in Pluronic F-127-coated cell culture vessels with a sequential administration of growth factor-and small-molecule-based cocktails to induce mesodermal progenitors, cardiac progenitors, and cardiomyocytes. Dissociation of differentiated cardiomyocytes was performed with collagenase, and dissociated cardiomyocytes were analyzed for cardiac differentiation efficiency by flow cytometry (cardiac troponin T) and subjected to EHT generation. All procedures involving the generation and analysis of hiPSC lines were approved by the local ethics committee in Hamburg (Az PV4798, 28.10.2014).
Sensor Plasmid, AAV and Lentiviral Vector Production, and Transduction of Cardiomyocytes
The details are described in the Supplemental Experimental Procedures.
Generation of Human Engineered Heart Tissue and GCaMP6f Transduction
Human EHTs were generated as recently described (Breckwoldt et al., 2017) . Frozen or freshly dissociated hiPSC-CMs were counted and a master mix was prepared. Nunc 24-well plates were used to generate casting molds with liquid agarose (2% in PBS, 1.5 mL per well) and Teflon spacers (EHT Technologies). After agarose solidification (10 min), Teflon spacers were removed, and PDMS racks (EHT Technologies) were placed on 24-well plates so that pairs of PDMS posts reached into each agarose casting mold. The master mix (97 mL) was briefly mixed with thrombin (3 mL) and pipetted into one agarose casting mold. This pipetting step was repeated for each casting mold with a new pipette tip to avoid thrombin carryover and fibrin polymerization in the pipette tip. Full plates of EHTs were incubated for 90 min in the incubator and 200-300 mL of EHT medium was added per well to ease removal of EHTs from agarose casting molds. PDMS racks with EHTs were transferred from the casting plate to an additional 24well plate, filled with EHT medium (1.5 mL/well), 2 h after casting. EHT medium was changed on Mondays, Wednesdays, and Fridays. Contractions of single cardiomyocytes were usually visible after 3-5 days, larger networks of cardiomyocytes started beating after 7-10 days, and synchronous contraction of the entire EHT was observed after 14 days. Transduction of human EHTs with GCaMP6f was performed by adding AAV6 particles (originally, MOI of 7 3 10 4 and 7 3 10 5 [genomic titer] were tested ( Figure 1E) , and for follow-up experiments, an MOI of 1 3 10 6 [genomic titer, Figure 1F ] was chosen) or lentiviral particles (MOI of 0.3, functional titer) into the master mix during casting. Analysis of CaT and force was performed on day 20-70.
Recording of Contractility and Calcium Transients
Automated sequential video-optical analyses for force and fluorescence-based CaT recordings under frequency control by electrical pacing (as recently described by Hirt et al., 2014) were performed as recently described ). An automated xy stage was built on an inverted fluorescence microscopy stage (Axiovert, Zeiss). The automated xy stage was covered with a light-tight temperature-and CO 2 -controlled homemade incubation chamber. A camera for force recording was connected to the front port of the microscope. A mercury lamp and GFP filter set were installed for fluorescent light excitation. The side port of the microscope was connected via beam splitter to a long-pass filter/photomultiplier and a camera to control the position for fluorescence recording. For the analysis, human EHTs were transferred into a cell-imaging 24-well plate (Eppendorf) equipped with graphite-based pacing electrodes. The plate was placed into the 24-well inlet of the microscope, and the plastic box covering the microscope was closed. The objective focus of the microscope served as the z axis on this stage. A customized software was used to control microscope settings, xyz coordinates, and objective revolver position. The xyz coordinates were defined and saved in the software for each EHT to perform automated force (1.253 objective) and CaT (103 objective) recordings.
Force was analyzed by video-optical recording as described in the past (Hansen et al., 2010; Mannhardt et al., 2016; Schaaf et al., 2011) . Software-based automated video-optical recording of EHT contractility was started. A video file was generated for each EHT (100 frames per second). A customized software algorithm automatically identified top and bottom ends of the EHT contour and followed these positions during the course of the contraction. Force was then calculated based on EHT shortening and the elastic propensity and geometry of the PDMS posts to which the EHTs were attached. Raw traces were plotted with force (y axis) over time (x axis), filtered (Gaussian filter), and baseline corrected. Contraction peak amplitudes were identified based on predefined contraction peak criteria and marked with a green square for visual quality control. Average values for force, frequency, and parameters of kinetics were calculated and summarized in a report file. This report also contained force graphs in which the electrical pacing signal was indicated with a vertical blue line ( Figure S2A ).
GCaMP fluorescence intensity was measured as a surrogate for CaT. The emitted fluorescent light from the GCaMP-transduced EHT in the well was reflected by the dichroic mirror and bandpass-filtered and sensed by the photomultiplier tube (PMT). The PMT converted light intensities into electrical signals and forwarded the signals (frame rate: 100 frames per second) to the customized software. Raw traces were plotted with intensities (y axis) over time (x axis), filtered (Gaussian filter), and baseline corrected. In filtered traces an automated peak identification algorithm identified CaT peaks and marked them with a green square for visual quality control. From there, CaT amplitude and kinetics were automatically calculated and summarized as mean values ± SD in a report file. This report also contained CaT graphs in which the electrical pacing signal was indicated with a vertical blue line ( Figure S2A ). CaT recordings were performed between 3 and 10 s. CaT that were incompletely displayed on this graph were excluded from the analysis. Signal-to-noise ratio was calculated based on CaT amplitudes and background signal intensity in original recordings ( Figure S2A ). Representativity of the area for CaT signal integration was presumed based on the homogeneity of the EHT structure and the calculation of mean values from 10 to 26 individual EHTs for the experiments presented in this paper.
Positive inotropic compounds were analyzed in Tyrode's solution at submaximal extracellular calcium concentrations close to the EC 50 values for the respective EHT batch, which were in the range of 0.5-1.0 mM calcium. For this, first, baseline force at 1.8 mM calcium was analyzed, and extracellular calcium was washed out until half-maximal force values were recorded. Afterward, recordings were done at baseline and 20-30 min after compound incubation. For the analysis, only contraction or CaT recordings were considered, in which the contractions/ CaT followed the pacing frequency. Recordings in which the EHTs were beating at a higher frequency than the pacing signal were excluded from the analysis. In case of artifacts or baseline drift during CaT recording, offline analysis was performed to exclude part of the recordings. Since CaT peaks were sometimes cut by this procedure and incomplete peaks were excluded from the analysis, recalculated frequency values after offline analysis showed lower values than actual pacing frequency.
Histological Analysis
Details are described in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical differences were determined by paired t test, one-way ANOVA with Dunnett's/Tukey's/Bonferroni's multiple comparisons posttest, and two-way ANOVA with Sidak's multiple comparisons posttest versus baseline as indicated in figure legends. Data presented within the text are listed as means ± SEM.
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